spd602
Showing 1 - 3 of 3
Transfusional Iron Overload, Iron Overload, Iron Chelation Trial (SPD602, Deferasirox)
Withdrawn
- Transfusional Iron Overload
- +6 more
- SPD602
- Deferasirox
- (no location specified)
Jun 1, 2021
Transfusional Iron Overload, Beta-Thalassemia Trial in Worldwide (SPD602)
Terminated
- Transfusional Iron Overload
- Beta-Thalassemia
- SPD602
-
Boston, Massachusetts
- +8 more
Jun 10, 2021
Iron Overload Due to Repeated Red Blood Cell Transfusions Trial in Worldwide (SPD602)
Terminated
- Iron Overload Due to Repeated Red Blood Cell Transfusions
- SPD602
-
Los Angeles, California
- +11 more
Jun 11, 2021